ARTICLE
|
doi:10.20944/preprints202105.0144.v1
Subject:
Medicine And Pharmacology,
Immunology And Allergy
Keywords:
luminal breast cancer; neoadjuvant therapy; neutrophil to lymphocyte ratio (NLR); platelet to lymphocyte ratio (PLR); predictive/prognostic biomarkers
Online: 7 May 2021 (12:26:14 CEST)